ArticleUrologia internationalis2022

Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy.

Ryuichi Mizuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.